AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2002 JAN 9 - (NewsRx.com & NewsRx.net) -- Protein Sciences Corp. (PSC) has signed a contract with the National Institute of Allergy and Infections Diseases (NIAID) that provides for up to $76 million in funding through mid-2006 for development and production of antigens for new vaccines for HIV/AIDS.
Under the contract, after NIAID approves a vaccine candidate it will issue a task order to fund Protein Sciences to develop and manufacture clinical materials suitable for Phase I, II and III human clinical trials. Industry and institutions in the U.S. or abroad qualify for funding.
"Our company has a long history of involvement in developing HIV/AIDS vaccines, and we have extensive experience in producing clinical materials to support large-scale human ...